Presenters
Clinical Associate Professor
Prof. Roger Chen, MD, MBBS (HON), FRACP, PhD
Course Details
The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple
Estimated time of Completion: 30 mins
CPD Points: 1 Point
PRC Program No: PROG-2022-42464
A Decade of Simplicity Experience in T2DM: Why it Matters? Course Outline:
- DPP4 Inhibitors – Mechanism of Action
- Linagliptin: Proven efficacy and safety in a broad range of patient profiles
- Overall Safety of Linagliptin as seen in CARMELINA® and CAROLINA®
- Linagliptin + Metformin Benefits
- Course Evaluation
PC-PH-104364 / October 2022